DaVita Raises 2024 Profit Forecast Amid Strong Dialysis Demandby Mark Eisenberg 07.08.2024DaVita increases 2024 profit outlook due to high demand for kidney dialysis services, boosting shares by 3% in aftermarket trade.
TG Therapeutics Raises 2024 Revenue Guidance Amid Soaring BRIUMVI Salesby Mark Eisenberg 07.08.2024TG Therapeutics' Q2 2024 results show BRIUMVI sales at $72.6M, prompting a revenue guidance raise to $290-$300M.
Hill Harper’s Tech and AI Strategy in His US Senate Campaignby Lilu Anderson 07.08.2024Hill Harper leverages technology and AI while ensuring data privacy and education in his historic US Senate campaign.
Amazon’s Just Walk Out Tech Gets Major AI Upgradeby Lilu Anderson 06.08.2024Amazon enhances its checkout-free Just Walk Out tech with transformer-based machine learning for better accuracy and efficiency.
Castle Biosciences Q2: Revenue Soars 74% to $87 Millionby Mark Eisenberg 06.08.2024Castle Biosciences reports 74% Q2 revenue surge to $87M, driven by test usage and price hikes, with net income rebounding ...
Solana & Ethereum: Market Rebound Insights & Future Trendsby John Darbie 06.08.2024Ethereum and Solana navigate key support amid volatility as markets react to global economic shifts. Investors eye critical levels for ...
Estee Lauder CFO Travis to Step Down After Over a Decadeby Mark Eisenberg 12.07.2024Estee Lauder’s CFO Tracey Travis to retire in June 2025 after 12 years, successor chosen, significant financial growth under her ...
Cryptocurrency Mining Equipment Market to Hit USD 15.11B by 2030by John Darbie 04.07.2024Cryptocurrency Mining Equipment Market to hit USD 15.11B by 2030, driven by crypto popularity, tech advances, and energy-efficient hardware trends.
Thai Banks Accused of Aiding Myanmar Military Financesby Mark Eisenberg 26.06.2024Thai banks finance Myanmar junta's war, UN expert reports. Financial support prolongs conflict and human rights abuses. International call to ...
Formation Bio Lands $372M Series D Amid AI-Driven Expansionby Lilu Anderson 26.06.2024Formation Bio secures $372M Series D led by Sanofi to enhance AI-driven drug development, focusing on workflow automation and AI ...